These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20701957)

  • 41. Inhibition of IGF-1-Mediated Cellular Migration and Invasion by Migracin A in Ovarian Clear Cell Carcinoma Cells.
    Ukaji T; Lin Y; Banno K; Okada S; Umezawa K
    PLoS One; 2015; 10(9):e0137663. PubMed ID: 26360832
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insulin-like growth factor 2 expression modulates Taxol resistance and is a candidate biomarker for reduced disease-free survival in ovarian cancer.
    Huang GS; Brouwer-Visser J; Ramirez MJ; Kim CH; Hebert TM; Lin J; Arias-Pulido H; Qualls CR; Prossnitz ER; Goldberg GL; Smith HO; Horwitz SB
    Clin Cancer Res; 2010 Jun; 16(11):2999-3010. PubMed ID: 20404007
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel mechanism of reduced proliferation in ovarian clear cell carcinoma cells: cytoplasmic sequestration of CDK2 by p27.
    Itamochi H; Yoshida T; Walker CL; Bartholomeusz C; Aoki D; Ishihara H; Suzuki N; Kigawa J; Terakawa N; Ueno NT
    Gynecol Oncol; 2011 Sep; 122(3):641-7. PubMed ID: 21652059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Significant clinical response of progressive recurrent ovarian clear cell carcinoma to glypican-3-derived peptide vaccine therapy: two case reports.
    Suzuki S; Shibata K; Kikkawa F; Nakatsura T
    Hum Vaccin Immunother; 2014; 10(2):338-43. PubMed ID: 24252799
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glypican-3 expression in clear cell adenocarcinoma of the ovary.
    Maeda D; Ota S; Takazawa Y; Aburatani H; Nakagawa S; Yano T; Taketani Y; Kodama T; Fukayama M
    Mod Pathol; 2009 Jun; 22(6):824-32. PubMed ID: 19329941
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways.
    Buchanan C; Stigliano I; Garay-Malpartida HM; Rodrigues Gomes L; Puricelli L; Sogayar MC; Bal de Kier Joffé E; Peters MG
    Breast Cancer Res Treat; 2010 Feb; 119(3):559-74. PubMed ID: 19288189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Establishment and characterization of a CA125-producing human ovarian clear cell carcinoma cell line].
    Sasa H; Ishii K; Hirata J; Kikuchi Y; Nagata I; Kawai T; Senoo A; Sugita M; Sugishita T; Tenjin Y
    Hum Cell; 1993 Dec; 6(4):279-86. PubMed ID: 8148309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytokine gene expression signature in ovarian clear cell carcinoma.
    Yanaihara N; Anglesio MS; Ochiai K; Hirata Y; Saito M; Nagata C; Iida Y; Takakura S; Yamada K; Tanaka T; Okamoto A
    Int J Oncol; 2012 Sep; 41(3):1094-100. PubMed ID: 22751940
    [TBL] [Abstract][Full Text] [Related]  

  • 49. GPC3 expression in mouse ovarian cancer induces GPC3‑specific T cell-mediated immune response through M1 macrophages and suppresses tumor growth.
    Luo C; Shibata K; Suzuki S; Kajiyama H; Senga T; Koya Y; Daimon M; Yamashita M; Kikkawa F
    Oncol Rep; 2014 Sep; 32(3):913-21. PubMed ID: 24992906
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010.
    Anglesio MS; Carey MS; Köbel M; Mackay H; Huntsman DG;
    Gynecol Oncol; 2011 May; 121(2):407-15. PubMed ID: 21276610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glypican 3 binds to GLUT1 and decreases glucose transport activity in hepatocellular carcinoma cells.
    Cho HS; Ahn JM; Han HJ; Cho JY
    J Cell Biochem; 2010 Dec; 111(5):1252-9. PubMed ID: 20803547
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Annexin A4 is involved in proliferation, chemo-resistance and migration and invasion in ovarian clear cell adenocarcinoma cells.
    Mogami T; Yokota N; Asai-Sato M; Yamada R; Koizume S; Sakuma Y; Yoshihara M; Nakamura Y; Takano Y; Hirahara F; Miyagi Y; Miyagi E
    PLoS One; 2013; 8(11):e80359. PubMed ID: 24244679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cystatin B as a potential diagnostic biomarker in ovarian clear cell carcinoma.
    Takaya A; Peng WX; Ishino K; Kudo M; Yamamoto T; Wada R; Takeshita T; Naito Z
    Int J Oncol; 2015 Apr; 46(4):1573-81. PubMed ID: 25633807
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma.
    Tsuchiya A; Sakamoto M; Yasuda J; Chuma M; Ohta T; Ohki M; Yasugi T; Taketani Y; Hirohashi S
    Am J Pathol; 2003 Dec; 163(6):2503-12. PubMed ID: 14633622
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Specific expression of hepatocyte nuclear factor-1beta in the ovarian clear cell adenocarcinoma and its application to cytological diagnosis.
    Higashiguchi A; Yamada T; Susumu N; Mori T; Suzuki A; Aoki D; Sakamoto M
    Cancer Sci; 2007 Mar; 98(3):387-91. PubMed ID: 17270029
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The biological property of ovarian cancers is affected by endometriosis--with special reference to ovarian clear cell adenocarcinoma].
    Aoki D; Komiyama S; Susumu N; Nozawa S
    Nihon Rinsho; 2001 Jan; 59 Suppl 1():213-6. PubMed ID: 11235169
    [No Abstract]   [Full Text] [Related]  

  • 57. OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner.
    Gonzalez AD; Kaya M; Shi W; Song H; Testa JR; Penn LZ; Filmus J
    J Cell Biol; 1998 Jun; 141(6):1407-14. PubMed ID: 9628896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. GPC3 reduces cell proliferation in renal carcinoma cell lines.
    Valsechi MC; Oliveira AB; Conceição AL; Stuqui B; Candido NM; Provazzi PJ; de Araújo LF; Silva WA; Calmon Mde F; Rahal P
    BMC Cancer; 2014 Aug; 14():631. PubMed ID: 25168166
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and may be a novel therapeutic approach.
    Itamochi H; Oumi N; Oishi T; Taniguchi F; Shoji T; Fujiwara H; Sugiyama T; Suzuki M; Kigawa J; Harada T
    Int J Gynecol Cancer; 2015 May; 25(4):570-6. PubMed ID: 25756405
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma.
    Kuo KT; Mao TL; Chen X; Feng Y; Nakayama K; Wang Y; Glas R; Ma MJ; Kurman RJ; Shih IeM; Wang TL
    Clin Cancer Res; 2010 Apr; 16(7):1997-2008. PubMed ID: 20233889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.